<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231114060052N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-10</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>the effect of implementing self-compassion training program  on self-compassion, adherence to treatment and anxiety of patients with multiple sclerosis</public_title>
      <acronym></acronym>
      <scientific_title>the effect of implementing self-compassion training program  on self-compassion, adherence to treatment and anxiety of patients with multiple sclerosis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73751</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: After obtaining written consent from the patient's legal guardian, they were assigned to two intervention and control groups by random allocation method and using permutation blocks. Considering that two groups are considered in the study, patients were allocated in six cases of blocks of four. (A care program group and B control group, for example AABB, ABAB, BBAA,...). There were two people from each group in each block. The order of the blocks was randomly determined using a table of random numbers, and then the patients were assigned to the intervention or control group based on the blocks. In this way, the researcher interviewed the patient, for each of the participants, the subject of the research, the objectives, the stages of the research, the voluntary nature of the participation in this research and the confidentiality of the information were explained, and finally, a written consent form was obtained from the patient or family and explained to the samples. It was given that they have the freedom to leave and continue the study, their non-participation or withdrawal will not affect their treatment, Blinding description: The patients of the MS center did not know which group they were in (intervention or control) and the training sessions were held in another place where they had no contact with the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>multiple sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: eight 45-minute sessions that were conducted in the form of an eight-day workshop twice a week for four weeks to the patients (in the MS Association of Zahedan) by a researcher and a consultant under the supervision of research team members and a neurologist. Session 1: Acquaintance and awareness: talk about the purpose of the meeting and its overall construction, (goal: checking the expectations of the treatment plan, getting to know the general principles of compassion-focused treatment. Explaining the disease, its causes, symptoms, methods treatment, diagnostic methods and complications of multiple sclerosis). Session 2: Introduction of self-compassion and self-criticism. (Aim: review of the previous session and review of how members deal with themselves (critical and self-compassionate style). Definition of self-criticism and its causes and consequences. Session 3: Introduction of the characteristics and skills of compassion. self and how it affects the mental states of the person, (purpose: review the assignment and review of the previous session; what is self-compassion? examining its characteristics and skills and how it affects the mental states of the person, introducing the three emotional regulation systems and how to interact with them Session 4: Introduction to mental imagery, (goal: Reviewing the assignment and review of the previous session introducing mental imagery and its logic. Teaching imagery practice and its implementation in the group (Imagination of color, place and characteristics of a compassionate person). Session 5: Education self-compassion and introduction of concepts: wisdom, ability, warmth and responsibility (goal: checking the assignment and review of the previous session; cultivating self-compassion and introduction of concepts: wisdom, ability, warmth and responsibility-responsibility in creating compassion, teaching how to portray about self-compassion).Session 6: Teaching self-compassion letter writing (goal: checking the assignment and reviewing the previous session of teaching self-compassion letter writing).Session 7: Explaining the fear of self-compassion and identifying thoughts that prevent the development of self-compassion (goal: Examining the assignment and review of the previous session fear of compassion to self-identify thoughts preventing the development of compassion for oneself and the user on them). their results from the group). Intervention 2: Control group: they will not receive education except usual care and at the same time interval as the intervention group, the post-test will also be done from the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The research team is very busy</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farshid Saidinezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan town, Farsh street, address 15</address>
        <city>shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>07189740003</zip>
        <telephone>+98 71 3342 2567</telephone>
        <email>farshidsaeedinezhad@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farshid Saeedinezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan town, Farsh street, Address 15</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7189740003</zip>
        <telephone>+98 71 3342 2567</telephone>
        <email>FARSHIDSAEEDINEZHAD@GMAIL.COM</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The research sample in this study included all patients with multiple sclerosis, members of the Multiple Sclerosis Association of Zahedan city, whose disease was confirmed by a neurologist and at least 6 months had passed since the diagnosis of their disease.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Occurrence of serious complications of the disease (severe movement disorder, vision), hospitalization or death of the patient during the study.
Absence of more than one session in the workshop.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G37.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Demyelinating disease of central nervous system, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: eight 45-minute sessions that were conducted in the form of an eight-day workshop twice a week for four weeks to the patients (in the MS Association of Zahedan) by a researcher and a consultant under the supervision of research team members and a neurologist. Session 1: Acquaintance and awareness: talk about the purpose of the meeting and its overall construction, (goal: checking the expectations of the treatment plan, getting to know the general principles of compassion-focused treatment. Explaining the disease, its causes, symptoms, methods treatment, diagnostic methods and complications of multiple sclerosis). Session 2: Introduction of self-compassion and self-criticism. (Aim: review of the previous session and review of how members deal with themselves (critical and self-compassionate style). Definition of self-criticism and its causes and consequences. Session 3: Introduction of the characteristics and skills of compassion. self and how it affects the mental states of the person, (purpose: review the assignment and review of the previous session; what is self-compassion? examining its characteristics and skills and how it affects the mental states of the person, introducing the three emotional regulation systems and how to interact with them Session 4: Introduction to mental imagery, (goal: Reviewing the assignment and review of the previous session introducing mental imagery and its logic. Teaching imagery practice and its implementation in the group (Imagination of color, place and characteristics of a compassionate person). Session 5: Education self-compassion and introduction of concepts: wisdom, ability, warmth and responsibility (goal: checking the assignment and review of the previous session; cultivating self-compassion and introduction of concepts: wisdom, ability, warmth and responsibility-responsibility in creating compassion, teaching how to portray about self-compassion).Session 6: Teaching self-compassion letter writing (goal: checking the assignment and reviewing the previous session of teaching self-compassion letter writing).Session 7: Explaining the fear of self-compassion and identifying thoughts that prevent the development of self-compassion (goal: Examining the assignment and review of the previous session fear of compassion to self-identify thoughts preventing the development of compassion for oneself and the user on them). their results from the group)</i_keyword>
      <i_keyword>Control group: they will not receive education except usual care and at the same time interval as the intervention group, the post-test will also be done from the control group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Adherence to treatment and anxiety. Timepoint: Start studying, 1 and 3 months later. Method of measurement: questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-09</approval_date>
        <contact_name>National system of ethics</contact_name>
        <contact_address>Golestan town, Farsh street, address 15 SHIRAZ Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
